Impax Loses Bid For Generic Version Of Rilutek
Impax Laboratories Inc.'s proposed generic version of Rilutek infringes on Aventis SA's patent for the brand version of the drug, a U.S. federal court has ruled....To view the full article, register now.
Already a subscriber? Click here to view full article